Mycosis fungoides screening: Difference between revisions

	Cutaneous T cell lymphoma Microchapters
Home
Patient Information
Overview
Classification Mycosis fungoides Sezary syndrome
Pathophysiology

Revision as of 17:16, 26 December 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cutaneous T cell lymphoma.

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cutaneous T cell lymphoma.

Revision as of 19:24, 21 December 2018 view source Sogand (talk \| contribs) 4,941 edits No edit summary ← Older edit	Revision as of 17:16, 26 December 2018 view source Anmol Pitliya (talk \| contribs) Bureaucrats, bureaucrats, nocaptcha, Administrators, Widget editors 9,217 edits m Anmol Pitliya moved page Cutaneous T cell lymphoma screening to Mycosis fungoides screening without leaving a redirect Newer edit →
(No difference)